Lu M C, Tache V, Alexander G R, Kotelchuck M, Halfon N
Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
J Matern Fetal Neonatal Med. 2003 Jun;13(6):362-80. doi: 10.1080/jmf.13.6.362.380.
To review the evidence of effectiveness of prenatal care for preventing low birth weight (LBW).
We reviewed original research, systematic reviews, meta-analyses and commentaries for evidence of effectiveness of the three core components of prenatal care--risk assessment, health promotion and medical and psychosocial interventions--for preventing the two constituents of LBW: preterm birth and intrauterine growth restriction (IUGR).
Clinical risk assessment will fail to identify the majority of pregnancies at risk for preterm delivery or IUGR. While biophysical and biochemical modalities appear promising, their cost-effectiveness has not been demonstrated, nor can their routine use be recommended in the absence of effective interventions. Smoking cessation programs appear to be modestly effective. There is insufficient evidence to conclude a benefit for nutrition interventions, work counseling or preterm birth education. Only antenatal corticosteroid therapy has demonstrated a clear benefit in the tertiary prevention of preterm delivery. Interventions for which there is insufficient evidence to conclude a benefit include bed rest, hydration, sedation, cerclage, progesterone supplementation, antibiotic treatment, tocolysis without concomitant use of corticosteroids, thyrotropin-releasing hormone, psychosocial support and home visitation. Additionally, there is a paucity of evidence supporting the effectiveness of prenatal interventions, such as low-dose aspirin, bed rest, maternal hyperoxygenation, plasma volume expansion and antenatal fetal assessment, in preventing IUGR or its associated morbidity and mortality.
Neither preterm birth nor IUGR can be effectively prevented by prenatal care in its present form. Preventing LBW will require reconceptualization of prenatal care as part of a longitudinally and contextually integrated strategy to promote optimal development of women's reproductive health not only during pregnancy, but over the life course.
回顾产前保健预防低出生体重(LBW)有效性的证据。
我们查阅了原始研究、系统评价、荟萃分析和评论,以获取产前保健的三个核心组成部分——风险评估、健康促进以及医学和心理社会干预——预防LBW的两个构成因素:早产和宫内生长受限(IUGR)有效性的证据。
临床风险评估无法识别大多数有早产或IUGR风险的妊娠。虽然生物物理和生化方法看起来很有前景,但它们的成本效益尚未得到证实,而且在缺乏有效干预措施的情况下,也不建议常规使用。戒烟计划似乎有一定效果。没有足够的证据得出营养干预、工作咨询或早产教育有益的结论。只有产前糖皮质激素治疗在早产的三级预防中显示出明显益处。没有足够证据得出有益结论的干预措施包括卧床休息、补液、镇静、宫颈环扎术、补充孕酮、抗生素治疗、不联合使用糖皮质激素的宫缩抑制、促甲状腺素释放激素、心理社会支持和家访。此外,也缺乏证据支持产前干预措施,如低剂量阿司匹林、卧床休息、母体高氧治疗、血浆容量扩充及产前胎儿评估,在预防IUGR或其相关发病和死亡方面的有效性。
目前形式的产前保健无法有效预防早产或IUGR。预防LBW需要重新构想产前保健,将其作为纵向和情境综合策略的一部分,以促进女性生殖健康的最佳发展,不仅在孕期,而且在整个生命过程中。